Patent ID: 7985562
Filing Date: 2011-07-26
Classification: G01N,Y10S

Abstract:
1. A method for identifying an inhibitor of TAFI-Ile347, for the therapy or prophylaxis of a thrombogenic disorder, wherein the method comprises: (a) providing a TAFI-Ile347 protein or a TAFI-Ile347 gene, (b) contacting the TAFI-Ile347 protein or the TAFI-Ile347 gene with a test compound, and (c) measuring or detecting an influence of the test compound on the TAFI-Ile347 protein or the TAFI-Ile347 gene wherein reduction in activity of the TAFI-Ile347 protein or the TAFI-Ile347 gene identifies the test compound as said inhibitor of TAFI-Ile347 for the therapy or prophylaxis of a thrombogenic disorder.